MYUNGMOON Pharm co.,Ltd (KRX:017180)

MYUNGMOON Pharm co.,Ltd Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 25, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	63,948	60,806	76,621	97,023	159,901	245,768
Market Cap Growth	11.68%	-20.64%	-21.03%	-39.32%	-34.94%	106.68%
Enterprise Value	159,387	151,088	159,448	175,770	244,712	325,526
Last Close Price	1913.00	1819.00	2285.00	2870.00	4730.00	7270.00
PE Ratio	44.26	-	-	12.33	-	-
PS Ratio	0.33	0.33	0.45	0.64	1.16	1.92
PB Ratio	0.62	0.59	0.86	1.02	1.86	2.71
P/TBV Ratio	0.66	0.63	0.92	1.09	2.00	2.84
P/FCF Ratio	-	-	-	25.91	332.93	-
P/OCF Ratio	45.82	-	-	17.72	187.02	-
EV/Sales Ratio	0.82	0.81	0.94	1.16	1.78	2.55
EV/EBITDA Ratio	13.37	25.21	31.07	16.47	-	-
EV/EBIT Ratio	20.27	78.34	165.44	27.32	-	-
EV/FCF Ratio	-65.14	-	-	46.95	509.51	-
Debt / Equity Ratio	0.93	0.85	1.02	0.87	0.98	1.09
Debt / EBITDA Ratio	8.07	14.60	17.63	7.79	-	-
Debt / FCF Ratio	-	-	-	22.21	175.17	-
Net Debt / Equity Ratio	0.86	0.80	0.89	0.77	0.86	0.94
Net Debt / EBITDA Ratio	7.51	13.80	15.36	6.86	-43.87	-3.46
Net Debt / FCF Ratio	-36.59	-39.23	-9.65	19.54	153.27	-4.59
Asset Turnover	0.77	0.75	0.73	0.67	0.59	0.50
Inventory Turnover	2.52	2.60	2.67	2.88	2.70	2.94
Quick Ratio	0.57	0.51	0.42	0.39	0.36	0.38
Current Ratio	0.97	0.87	0.70	0.64	0.60	0.64
Return on Equity (ROE)	0.84%	-3.95%	-5.30%	8.81%	-7.70%	-32.46%
Return on Assets (ROA)	1.96%	0.49%	0.26%	1.77%	-1.58%	-7.13%
Return on Invested Capital (ROIC)	1.31%	1.09%	0.57%	3.92%	-3.50%	-15.83%
Return on Capital Employed (ROCE)	4.50%	1.20%	0.80%	5.40%	-5.30%	-24.60%
Earnings Yield	2.28%	-4.99%	-5.91%	8.11%	-4.29%	-11.25%
FCF Yield	-3.83%	-3.47%	-10.65%	3.86%	0.30%	-7.60%
Buyback Yield / Dilution	-0.14%	0.58%	0.38%	-	-15.48%	-20.01%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.